Change in IS [Bioanalytics]

posted by ketan – India, 2012-10-12 10:57 (4611 d 23:07 ago) – Posting: # 9401
Views: 3,106

Dear All,

We have to carry out pivotal study for which we have validated method in which internal standard used was not deteurated or labeled molecule, but now we are planning to go for deuterated IS and again re-validate the method before subject analysis therefore I would like to know whether this change in IS for pivotal study is acceptable to the regulatory.

Regards,
Ketan

Complete thread:

UA Flag
Activity
 Admin contact
23,424 posts in 4,927 threads, 1,674 registered users;
47 visitors (0 registered, 47 guests [including 10 identified bots]).
Forum time: 10:04 CEST (Europe/Vienna)

It’s difficult to work in a group
when you are omnipotent.    John de Lancie (as Q)

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5